Globally, in 2023, approximately 1.4 million children aged 0 to 14 live with HIV, which is a significant decrease compared to 2010, when the number was 2.5 million. However, only 57% of these children have access to essential antiretroviral treatments, which emphasizes the urgent need to improve access to quality healthcare for them.
Access to antiretroviral therapy is essential not only for maintaining the health of these children, but also for preventing complications associated with the disease. Prevention of vertical transmission, ie from mother to child, has also been an important success, with 84% of HIV-pregnant women receiving treatments to reduce the risk of transmission to the newborn (World Health Organization (WHO),
By using HChat, doctors can quickly access the resources needed to make informed decisions, thus contributing to better care for these vulnerable children. The platform is designed to be available non-stop, removing barriers to access to information and ensuring that every child receives the care they need.
HChat not only improves access to medical knowledge, but also supports the prevention of complications associated with treatment, through detailed analysis of drug interactions. This is crucial in the context of childcare, where treatments require increased attention and rigorous personalization.
To explore how HChat can help improve the care of HIV-affected children, visit www.hchat.ro and learn more about this indispensable tool for health professionals. Together, we can make a significant difference in the lives of these children.
launch HChat it is an important moment in the field of health, bringing advanced technologies and essential information to the reach of medical professionals. HChat was developed and maintained with the help of financial support received from Gilead Sciences and the Society of Infectious Diseases and HIV / AIDS.
